213 related articles for article (PubMed ID: 23185371)
1. The transcription factor GLI1 mediates TGFβ1 driven EMT in hepatocellular carcinoma via a SNAI1-dependent mechanism.
Zheng X; Vittar NB; Gai X; Fernandez-Barrena MG; Moser CD; Hu C; Almada LL; McCleary-Wheeler AL; Elsawa SF; Vrabel AM; Shire AM; Comba A; Thorgeirsson SS; Kim Y; Liu Q; Fernandez-Zapico ME; Roberts LR
PLoS One; 2012; 7(11):e49581. PubMed ID: 23185371
[TBL] [Abstract][Full Text] [Related]
2. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
3. CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Zheng X; Song T; Dou C; Jia Y; Liu Q
Oncotarget; 2015 Feb; 6(6):3752-69. PubMed ID: 25686837
[TBL] [Abstract][Full Text] [Related]
4. Caveolin-1 is up-regulated by GLI1 and contributes to GLI1-driven EMT in hepatocellular carcinoma.
Gai X; Lu Z; Tu K; Liang Z; Zheng X
PLoS One; 2014; 9(1):e84551. PubMed ID: 24454730
[TBL] [Abstract][Full Text] [Related]
5. HOXB9 promotes epithelial-to-mesenchymal transition via transforming growth factor-β1 pathway in hepatocellular carcinoma cells.
Sha L; Dong L; Lv L; Bai L; Ji X
Clin Exp Med; 2015 Feb; 15(1):55-64. PubMed ID: 25081022
[TBL] [Abstract][Full Text] [Related]
6. Gli1 promotes transforming growth factor-beta1- and epidermal growth factor-induced epithelial to mesenchymal transition in pancreatic cancer cells.
Liu Q; Sheng W; Dong M; Dong X; Dong Q; Li F
Surgery; 2015 Jul; 158(1):211-24. PubMed ID: 25979438
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia Accelerates Aggressiveness of Hepatocellular Carcinoma Cells Involving Oxidative Stress, Epithelial-Mesenchymal Transition and Non-Canonical Hedgehog Signaling.
Liu Z; Tu K; Wang Y; Yao B; Li Q; Wang L; Dou C; Liu Q; Zheng X
Cell Physiol Biochem; 2017; 44(5):1856-1868. PubMed ID: 29237157
[TBL] [Abstract][Full Text] [Related]
8. The glioma-associated oncogene homolog 1 promotes epithelial--mesenchymal transition in human esophageal squamous cell cancer by inhibiting E-cadherin via Snail.
Min S; Xiaoyan X; Fanghui P; Yamei W; Xiaoli Y; Feng W
Cancer Gene Ther; 2013 Jul; 20(7):379-85. PubMed ID: 23788111
[TBL] [Abstract][Full Text] [Related]
9. The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma.
Deng G; Zeng S; Ma J; Zhang Y; Qu Y; Han Y; Yin L; Cai C; Guo C; Shen H
Sci Rep; 2017 Jan; 7():41616. PubMed ID: 28134289
[TBL] [Abstract][Full Text] [Related]
10. MiR-150 alleviates EMT and cell invasion of colorectal cancer through targeting Gli1.
Fan H; Liu X; Zheng WW; Zhuang ZH; Wang CD
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4853-4859. PubMed ID: 29164577
[TBL] [Abstract][Full Text] [Related]
11. PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1.
Li Q; Liu Z; Xu M; Xue Y; Yao B; Dou C; Jia Y; Wang Y; Tu K; Zheng X; Yao Y
Cancer Lett; 2016 May; 375(1):190-198. PubMed ID: 26945969
[TBL] [Abstract][Full Text] [Related]
12. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
13. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma.
Chen J; Zhu H; Liu Q; Ning D; Zhang Z; Zhang L; Mo J; Du P; Liu X; Song S; Fan Y; Liang H; Liu J; Zhang B; Chen X
J Exp Clin Cancer Res; 2019 Jun; 38(1):273. PubMed ID: 31228948
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma.
Malfettone A; Soukupova J; Bertran E; Crosas-Molist E; Lastra R; Fernando J; Koudelkova P; Rani B; Fabra Á; Serrano T; Ramos E; Mikulits W; Giannelli G; Fabregat I
Cancer Lett; 2017 Apr; 392():39-50. PubMed ID: 28161507
[TBL] [Abstract][Full Text] [Related]
15. Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway.
Wang J; Zhang N; Han Q; Lu W; Wang L; Yang D; Zheng M; Zhang Z; Liu H; Lee TH; Zhou XZ; Lu KP
Cancer Lett; 2019 Mar; 444():82-93. PubMed ID: 30583078
[TBL] [Abstract][Full Text] [Related]
16. Transcription factor glioma-associated oncogene homolog 1 is required for transforming growth factor-β1-induced epithelial-mesenchymal transition of non-small cell lung cancer cells.
Li H; Da LJ; Fan WD; Long XH; Zhang XQ
Mol Med Rep; 2015 May; 11(5):3259-68. PubMed ID: 25586417
[TBL] [Abstract][Full Text] [Related]
17. SNAI1 Promotes the Cholangiocellular Phenotype, but not Epithelial-Mesenchymal Transition, in a Murine Hepatocellular Carcinoma Model.
Xu M; Wang J; Xu Z; Li R; Wang P; Shang R; Cigliano A; Ribback S; Solinas A; Pes GM; Evert K; Wang H; Song X; Zhang S; Che L; Pascale RM; Calvisi DF; Liu Q; Chen X
Cancer Res; 2019 Nov; 79(21):5563-5574. PubMed ID: 31383647
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Twist is involved in Gli1 induced migration and invasion of hepatocarcinoma cells.
Li J; He Y; Cao Y; Yu Y; Chen X; Gao X; Hu Q
Biol Chem; 2018 Jul; 399(8):911-919. PubMed ID: 29908118
[TBL] [Abstract][Full Text] [Related]
19. PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
Zhou W; Gong L; Wu Q; Xing C; Wei B; Chen T; Zhou Y; Yin S; Jiang B; Xie H; Zhou L; Zheng S
J Exp Clin Cancer Res; 2018 Sep; 37(1):215. PubMed ID: 30180906
[TBL] [Abstract][Full Text] [Related]
20. AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGFβ1-ERK2 pathways.
Xu MY; Chen R; Yu JX; Liu T; Qu Y; Lu LG
Cancer Lett; 2016 May; 374(2):241-9. PubMed ID: 26902423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
